News & Events about Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) announced its actual results today for the first quarter ended March 31, 2023. We are very pleased with our strong first quarter results and start to 2023. We are confident in our continued momentum driven by the broad-based strength...
Amneal Pharmaceuticals, Inc. (NYSE:AMRX Get Rating) has received a consensus rating of Moderate Buy from the six ratings firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and three have given a buy...
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its first quarter 2023 financial results on Friday May 5, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on May 5...
Amneal Pharmaceuticals, Inc. (NYSE:AMRX Get Rating) has earned a consensus recommendation of Moderate Buy from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy ...
Ticker Report
2 months ago
Amneal Pharmaceuticals (NYSE:AMRX Get Rating) had its price target dropped by Truist Financial from $5.00 to $4.00 in a research note issued to investors on Wednesday, The Fly reports. The brokerage currently has a buy rating on the stock. Truist Financials target price ...